- Home
- NOTV vs WEA Comparison
NOTV vs WEA Comparison
Compare NOTV & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- WEA
- Stock Information
- Founded
- NOTV 1974
- WEA 2002
- Country
- NOTV United States
- WEA United States
- Employees
- NOTV N/A
- WEA N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- WEA Trusts Except Educational Religious and Charitable
- Sector
- NOTV Health Care
- WEA Finance
- Exchange
- NOTV Nasdaq
- WEA Nasdaq
- Market Cap
- NOTV 137.5M
- WEA 129.0M
- IPO Year
- NOTV 1997
- WEA N/A
- Fundamental
- Price
- NOTV $1.64
- WEA $10.73
- Analyst Decision
- NOTV Strong Buy
- WEA
- Analyst Count
- NOTV 3
- WEA 0
- Target Price
- NOTV $5.92
- WEA N/A
- AVG Volume (30 Days)
- NOTV 1.2M
- WEA 46.1K
- Earning Date
- NOTV 05-09-2025
- WEA 01-01-0001
- Dividend Yield
- NOTV N/A
- WEA 7.87%
- EPS Growth
- NOTV N/A
- WEA N/A
- EPS
- NOTV N/A
- WEA N/A
- Revenue
- NOTV $475,114,000.00
- WEA N/A
- Revenue This Year
- NOTV $6.07
- WEA N/A
- Revenue Next Year
- NOTV $5.74
- WEA N/A
- P/E Ratio
- NOTV N/A
- WEA N/A
- Revenue Growth
- NOTV N/A
- WEA N/A
- 52 Week Low
- NOTV $1.15
- WEA $9.60
- 52 Week High
- NOTV $6.48
- WEA $11.29
- Technical
- Relative Strength Index (RSI)
- NOTV 38.13
- WEA 49.49
- Support Level
- NOTV $1.15
- WEA $10.16
- Resistance Level
- NOTV $1.85
- WEA $10.77
- Average True Range (ATR)
- NOTV 0.44
- WEA 0.26
- MACD
- NOTV -0.05
- WEA -0.00
- Stochastic Oscillator
- NOTV 28.16
- WEA 46.72
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About WEA Western Asset Bond Fund Share of Beneficial Interest
Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.